Cicero® reposted this
HealththinkPost#37 We are feeling increasingly bullish on 2025 healthcare PE deal flow activity. Likely not 2021 levels, but an uptick--nonetheless. Key drivers will be reduced cost of capital, pent up demand--significant dry powder, and valuation resets. Spaces we believe will see increased activity include--ASCs; HCIT; RCM; specialty pharmacy; ambulatory infusion; hospice; behavioral health; CROs; and clinical trial sites, among others. We are looking forward to supporting buy and sell-side M&A activity! We can feel and see it coming. #Cicero #MGT #Healthcare
